McKesson Corporation (mck)
MCK — Company Overview
Investors tracking MCK follow a Medical Distribution name listed on NYQ within Healthcare.
| Ticker | MCK |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Exchange | NYQ |
| Market cap | $102.66B |
| Last price | $880.50 |
| Size category | Large Cap |
MCK — Business Description
The business profile of McKesson Corporation (MCK) reflects its role in Medical Distribution. McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmac…
Official website: https://www.mckesson.com.
MCK — Investment Thesis
McKesson Corporation (MCK) attracts investors weighing Medical Distribution fundamentals against current market pricing.
- Revenue is expanding at roughly 7.7% year-over-year (public data).
- Trailing P/E of 23.47× sits in a moderate band relative to high-growth peers.
- Forward P/E (17.45×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $102.66B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
MCK — Financial Health
MCK financial profile reflects operating efficiency and capital structure using available market fundamentals.
Profit margin near 1.1% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $6.80B supports balance-sheet flexibility.
| Trailing P/E | 23.47× |
| Forward P/E | 17.45× |
| Price / Sales | 0.25× |
| Price / Book | -24.09× |
| Gross margin | 3.6% |
| Operating margin | 1.3% |
| Profit margin | 1.1% |
| Free cash flow | $6.80B |
MCK — Growth Outlook
Growth outlook for McKesson Corporation (MCK) depends on demand trends in Medical Distribution and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 7.7% suggests steady but measured expansion.
- Earnings declined -17.6% year-over-year — margin or volume pressure may be in play.
- Price is 11.9% below the 52-week high.
- Shares trade 23.1% above the 52-week low — limited rebound so far.
MCK — Competitive Position
McKesson Corporation (MCK) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Medical Distribution.
- Market capitalization of $102.66B places MCK among large-cap peers.
- Gross margin of 3.6% should be benchmarked against direct competitors.
MCK — Strengths
Strengths for McKesson Corporation (MCK) inferred from public financial metrics:
- Revenue growth of 7.7% year-over-year.
- Positive free cash flow ($6.80B).
- Large Cap scale ($102.66B) may provide distribution and funding advantages.
MCK — Weaknesses
Weaknesses and pressure points for McKesson Corporation (MCK) based on available data:
- Earnings decline of -17.6% year-over-year.
- Thin profit margin (1.1%).
MCK — Opportunities
- Trading 23.1% above the 52-week low — potential recovery if fundamentals stabilize.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
MCK — Risks
- Thin margins leave less room for operational missteps.
MCK — Summary
McKesson Corporation (MCK) is a large-cap Healthcare company focused on Medical Distribution, listed on NYQ. Last price $880.50 with market cap $102.66B. Trailing P/E 23.47×. Revenue grew 7.7% year-over-year per public data. Notable strengths include revenue growth of 7.7% year-over-year. Key watch items include earnings decline of -17.6% year-over-year. Review free estimates and earnings pages for MCK; upgrade for institutional ownership and live headlines.
Start Free — open MCK in Vest Terminal
Access live data, filings, ownership, and analysis for McKesson Corporation.
McKesson Corporation FAQ
What does McKesson Corporation (MCK) do?
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes bra…
What is MCK's P/E ratio?
McKesson Corporation has a trailing P/E of 23.47× based on publicly available market data.
Does MCK pay a dividend?
Indicated dividend yield: 0.4%. Confirm ex-dates and payout history in Vest Terminal.
What sector is MCK in?
McKesson Corporation is classified in Healthcare (Medical Distribution) on NYQ.
What is MCK's market capitalization?
Approximate market cap: $102.66B.
What are the main risks for MCK?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of MCK?
Potential positives include revenue growth of 7.7% year-over-year, positive free cash flow ($6.80b).
Where can I get analyst estimates for MCK?
Public analyst price targets and consensus for McKesson Corporation are on the free /stocks/mck/estimates page. Deeper estimate history and models are available in Vest Terminal.